A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-la (BIIB017) in Subjects with Relapsing Multiple Sclerosis
|Effective start/end date||5/1/09 → 3/31/13|
- BIOGEN INC
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.